The store will not work correctly when cookies are disabled.
N-(thiazol-4-yl)pyrimidine-5-carboxamide
ID: ALA4087622
PubChem CID: 137644853
Max Phase: Preclinical
Molecular Formula: C8H6N4OS
Molecular Weight: 206.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cscn1)c1cncnc1
Standard InChI: InChI=1S/C8H6N4OS/c13-8(6-1-9-4-10-2-6)12-7-3-14-5-11-7/h1-5H,(H,12,13)
Standard InChI Key: SXZACLCRWHYDQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
14 15 0 0 0 0 0 0 0 0999 V2000
24.3121 -9.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3109 -10.6464 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0190 -11.0554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7286 -10.6460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7258 -9.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0172 -9.4180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4370 -11.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4383 -11.8706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1441 -10.6437 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8524 -11.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9418 -11.8614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7414 -12.0300 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.1489 -11.3216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6010 -10.7153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 206.23 | Molecular Weight (Monoisotopic): 206.0262 | AlogP: 1.19 | #Rotatable Bonds: 2 |
Polar Surface Area: 67.77 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.05 | CX Basic pKa: 0.98 | CX LogP: 0.39 | CX LogD: 0.39 |
Aromatic Rings: 2 | Heavy Atoms: 14 | QED Weighted: 0.80 | Np Likeness Score: -2.04 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |